Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/VA/Alexandria
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Alexandria, VA

Studies commonly pay $75 to $4,500 per completed study

2,303 clinical trials are currently recruiting participants within 30 miles of Alexandria. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,303studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Alexandria right now

Top 25 of 2,303 recruiting studies, sorted by proximity — each links to its official registry page

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Georgetown University - Lombardi CCC — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Abramson Cancer Center at Penn Medicine

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Georgetown University Medical Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Relay Therapeutics, Inc.

Using Aspirin to Improve Immunological Features of Ovarian Tumors

Ovarian Cancer, Fallopian Tube Cancer EARLY/Phase 1 Interventional 100 participants sought
Inova Schar Cancer Institute — Fairfax, Virginia (12.0 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma Phase 1 Interventional 25 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Cancer Institute (NCI)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Retina Group of Washington — Chevy Chase, Maryland (12.8 mi) · Sponsor: Genentech, Inc.

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma, Lymphoma Phase 2 Interventional 152 participants sought
Georgetown University (Data Collection Only) — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Memorial Sloan Kettering Cancer Center

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG Phase 2 Interventional 60 participants sought
Children's National Medical Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Nationwide Children's Hospital

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Human Papilloma Virus, Anal Dysplasia Phase 2 Interventional 120 participants sought
RIIS Clinic at HIPS — Washington D.C., District of Columbia (5.9 mi) · Sponsor: University of Maryland, Baltimore

The Pathogenesis and Natural History of Sjogren's Disease

Sjogren's Syndrome, Salivary Gland N/A Observational 300 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis Phase 2 Interventional 180 participants sought
Georgetown University — Washington D.C., District of Columbia (5.9 mi) · Sponsor: ACADIA Pharmaceuticals Inc.

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Avenzo Therapeutics, Inc.

Diagnosis and Treatment of Leishmania Infections

Leishmaniasis, Skin Diseases, Parasitic N/A Observational 289 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Phase 1 Interventional 248 participants sought
National Institutes of Health Clinical Center — Bethesda, Maryland (11.2 mi) · Sponsor: Nurix Therapeutics, Inc.

Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation

Rotator Cuff Tears, Rotator Cuff Injuries Phase 4 Interventional 100 participants sought
Walter Reed National Military Medical Center — Bethesda, Maryland (11.2 mi) · Sponsor: Brooke Army Medical Center

Zenith® Fenestrated+ Clinical Study

Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm N/A Interventional 105 participants sought
Medstar Washington Hospital Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Cook Research Incorporated

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS Phase 1 Interventional 50 participants sought
Childrens National Medical Center — Washington D.C., District of Columbia (5.9 mi) · Sponsor: Catherine Bollard

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial

Tibial Fractures, Pain Phase 3 Interventional 1,000 participants sought
Inova Fairfax Hospital — Falls Church, Virginia (6.4 mi) · Sponsor: Major Extremity Trauma Research Consortium

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer, Tumor, Solid Phase 1, Phase 2 Interventional 168 participants sought
NEXT Virginia — Fairfax, Virginia (12.0 mi) · Sponsor: OncoResponse, Inc.

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Vienna, Virginia (11.2 mi) · Sponsor: Retension Pharmaceuticals. Inc.

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
The Retina Group of Washington — Fairfax, Virginia (12.0 mi) · Sponsor: Astellas Pharma Global Development, Inc.
Google-rated

Top-rated research centers in Alexandria

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MD Medical Research

★ 4.9
6357 Oxon Hill Rd Fl 2, Oxon Hill, MD 20745
(301) 329-2612
"Maluu is so kind and professional ❤️"
— Tiffany West, 5★

Emerson Clinical Research Institute

★ 4.7
1718 Connecticut Ave NW, Washington, DC 20009
(202) 239-0777
"10/10 Vengan a Emerson Clinic que Wendy y Eliana son amables y tienen tanta paciencia para atenderlos. La clínica tiene recursos que ayudan y el doct…"
— Luis Mejia, 5★

NIH Clinical Center

★ 4.6
10 Center Dr, Bethesda, MD 20892
(301) 496-4000
"Fantastic staff. Very professional and welcoming."
— Paul, 5★

Millennium Clinical Trials

3801 Fairfax Dr #32, Arlington, VA 22203
(703) 527-8100

Terrain Clinic

★ 5.0
113 Oronoco St, Alexandria, VA 22314
(703) 269-0589

National Center for Health Research

1001 Connecticut Ave NW #1100, Washington, DC 20036
(202) 223-4000

Velocity Clinical Research

★ 5.0
4910 Massachusetts Ave NW Ste. 315, Washington, DC 20016
(202) 998-3833
"Very great staff and respectful"
— Reginald Simms, 5★

Foundation For Physical Therapy Research

3030 Potomac Ave, Alexandria, VA 22305
(800) 875-1378

Inova Schar Cancer Clinical Trials (A dept of Fairfax Hospital)

8081 Innovation Park Dr 8th floor, Fairfax, VA 22031
(571) 472-4724

Clinical trials in Alexandria: what's recruiting

The Alexandria area currently has 2,303 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Alexandria, the most active research areas are:

  • Cancer & Oncology12 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Alexandria, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Alexandria

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Alexandria participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Alexandria pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Alexandria?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Alexandria safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
What is the difference between a research center and a hospital study in Alexandria?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Alexandria typically complete one or two studies per year.

Paid clinical trials near Alexandria

Other metros within reach

More of VA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts